CAS No. : 1047634-63-8

Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000262
Molecular Formula:C18H16Cl2F2N4OS
Molecular Weight:445.31
IC50:0.08/2/2.6 nM(Akt1/Akt2/Akt3) [1]
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Cat No:I000262
Cas No:1047634-63-8

GSK2110183 is an orally bioavailable, selective, ATP-competitive and potent pan-Akt inhibitor with IC50s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.
IC50 value: 0.08/2/2.6 nM(Akt1/Akt2/Akt3) [1]
Target: Akt
GSK2110183 showed concentration-dependent effect on multiple AKT substrate phosphorylation levels, including GSK3β, PRAS40, FOXO and Caspase 9 in BT474 (breast; ERBB2+, PIK3CA K111N) and LNCaP (prostate; PTEN null). Mice bearing BT474 breast tumor xenografts were dosed orally with either vehicle or GSK2110183 at 10, 30 or 100 mg/kg daily for 21 days which resulted in 8, 37 and 61% TGI, respectively. Similarly, mice treated with GSK2110183 at 10, 30 and 100 mg/kg resulted in 23, 37 and 97% TGI, respectively, of SKOV3 xenografts.

[1]. Dumble M, et al. Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor. PLoS One. 2014 Jun 30;9(6):e100880.

Related Products
  • CAS No. :1047635-80-2
    Product Name:

    GSK2141795 hydrochloride

    Cat No: I000264 View details
  • CAS No. :1143532-39-1
    Product Name:


    Cat No: I000539 View details
  • CAS No. :20784-50-3
    Product Name:


    Cat No: I002599 View details
  • CAS No. :1047634-65-0
    Product Name:


    Cat No: I000263 View details